3-Dimensional Pharmaceuticals Selected Financial Information Expected net income after tax next year before new financing $40 million. Sinking-fund payments due next year on existing debt $14 million Interest due next year on existing debt $15 million Company tax rate 30% Common stock price, per share $20 $18 million Common shares outstanding Please refer to the financial information for 3-Dimensional Pharmaceuticals above. Calculate 3-Dimensional Pharmaceuticals' times-interest-earned ratio for next year assuming the firm raises $40 million of new debt at an interest rate of 7 percent. O 3.93 4.35 04.26 04.05 Next Last checked at 9:03pm Submit Q